Pfizer Investment

Pfizer is one of the world's largest research-based biopharmaceutical companies, engaged in the discovery, development, and manufacturing of healthcare products. The company maintains a diverse portfolio that includes internal medicine, oncology, inflammation and immunology, rare diseases, and vaccines. Pfizer gained significant global prominence for its development of the Comirnaty COVID-19 vaccine and the Paxlovid antiviral treatment. Following the 2023 acquisition of Seagen, Pfizer has significantly expanded its oncology pipeline, particularly in antibody-drug conjugates (ADCs). The company operates globally with a robust commercial infrastructure and a deep pipeline spanning from early-stage research to late-phase clinical trials.